Literature DB >> 21997133

Race and subset analyses in clinical trials: time to get serious about data integration.

Blase N Polite, Brooke E Sylvester, Olufunmilayo I Olopade.   

Abstract

Mesh：

Year:  2011        PMID： 21997133      PMCID： PMC3196483          DOI： 10.1093/jnci/djr382

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  30 in total

1.  Racial disparities in stage-specific colorectal cancer mortality: 1960-2005.

Authors:  Samir Soneji; Shally Shalini Iyer; Katrina Armstrong; David A Asch
Journal:  Am J Public Health       Date:  2010-08-19       Impact factor: 9.308

2.  P53 overexpression predicts poor chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resection.

Authors:  Jin-Tung Liang; Kuo-Chin Huang; Yung-Ming Cheng; Hey-Chi Hsu; Ann-Lii Cheng; Chih-Hung Hsu; Kun-Huei Yeh; Shih-Ming Wang; King-Jen Chang
Journal:  Int J Cancer       Date:  2002-02-01       Impact factor: 7.396

3.  Molecular predictors of survival after adjuvant chemotherapy for colon cancer.

Authors:  T Watanabe; T T Wu; P J Catalano; T Ueki; R Satriano; D G Haller; A B Benson; S R Hamilton
Journal:  N Engl J Med       Date:  2001-04-19       Impact factor: 91.245

4.  Exploring racial differences in outcome and treatment for metastatic colorectal cancer: results from a large prospective observational cohort study (BRiTE).

Authors:  Blase N Polite; Amy Sing; Daniel J Sargent; Axel Grothey; Jordan Berlin; Mark Kozloff; Shibao Feng
Journal:  Cancer       Date:  2011-07-28       Impact factor: 6.860

5.  Outcomes among African-Americans and Caucasians in colon cancer adjuvant therapy trials: findings from the National Surgical Adjuvant Breast and Bowel Project.

Authors:  J J Dignam; L Colangelo; W Tian; J Jones; R Smith; D L Wickerham; N Wolmark
Journal:  J Natl Cancer Inst       Date:  1999-11-17       Impact factor: 13.506

6.  Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status.

Authors:  Eric Van Cutsem; Claus-Henning Köhne; István Láng; Gunnar Folprecht; Marek P Nowacki; Stefano Cascinu; Igor Shchepotin; Joan Maurel; David Cunningham; Sabine Tejpar; Michael Schlichting; Angela Zubel; Ilhan Celik; Philippe Rougier; Fortunato Ciardiello
Journal:  J Clin Oncol       Date:  2011-04-18       Impact factor: 44.544

7.  DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy.

Authors:  Frank A Sinicrope; Nathan R Foster; Stephen N Thibodeau; Silvia Marsoni; Genevieve Monges; Roberto Labianca; George P Kim; Greg Yothers; Carmen Allegra; Malcolm J Moore; Steven Gallinger; Daniel J Sargent
Journal:  J Natl Cancer Inst       Date:  2011-05-19       Impact factor: 13.506

8.  Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials.

Authors:  Greg Yothers; Daniel J Sargent; Norman Wolmark; Richard M Goldberg; Michael J O'Connell; Jacqueline K Benedetti; Leonard B Saltz; James J Dignam; A William Blackstock
Journal:  J Natl Cancer Inst       Date:  2011-10-12       Impact factor: 13.506

9.  Outcomes and toxicity in african-american and caucasian patients in a randomized adjuvant chemotherapy trial for colon cancer.

Authors:  A David McCollum; Paul J Catalano; Daniel G Haller; Robert J Mayer; John S Macdonald; Al B Benson; Charles S Fuchs
Journal:  J Natl Cancer Inst       Date:  2002-08-07       Impact factor: 13.506

10.  Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer.

Authors:  Christine M Ribic; Daniel J Sargent; Malcolm J Moore; Stephen N Thibodeau; Amy J French; Richard M Goldberg; Stanley R Hamilton; Pierre Laurent-Puig; Robert Gryfe; Lois E Shepherd; Dongsheng Tu; Mark Redston; Steven Gallinger
Journal:  N Engl J Med       Date:  2003-07-17       Impact factor: 91.245
View more
  2 in total

1.  Race, ethnicity, and the diagnosis of breast cancer.

Authors:  Bobby Daly; Olufunmilayo I Olopade
Journal:  JAMA       Date:  2015-01-13       Impact factor: 56.272

2.  Molecular analysis of colorectal tumors within a diverse patient cohort at a single institution.

Authors:  Brooke E Sylvester; Dezheng Huo; Andrey Khramtsov; Jing Zhang; Rana V Smalling; Sope Olugbile; Blase N Polite; Olufunmilayo I Olopade
Journal:  Clin Cancer Res       Date:  2011-11-23       Impact factor: 12.531
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.